Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11309161rdf:typepubmed:Citationlld:pubmed
pubmed-article:11309161lifeskim:mentionsumls-concept:C0021701lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C0343804lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C1334087lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C0205322lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C0439662lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C1709059lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C0332120lld:lifeskim
pubmed-article:11309161lifeskim:mentionsumls-concept:C0253307lld:lifeskim
pubmed-article:11309161pubmed:issue5lld:pubmed
pubmed-article:11309161pubmed:dateCreated2001-4-19lld:pubmed
pubmed-article:11309161pubmed:abstractTextWe have previously shown that titers of soluble platelet selectin (s-P-selectin) and soluble vascular cell adhesion molecule-1 (s-VCAM-1) were increased in sera of patients with chronic Trypanosoma cruzi infection. In this study, we analyzed the expression of CD49d-integrins, that bind to VCAM-1, and sialyl Lewis x (SLe(x)), which binds selectins, in peripheral blood lymphocytes of 27 patients with Chagas' disease at different levels of disease severity. Patients with a mild form of Chagas' disease showed a lower number of CD49d(+) cells, in comparison with those with severe chronic cardiopathy. Decreased levels of CD49d(+) cells were detected in CD3(-) cell populations. Conversely, SLe(x) expression was found to be decreased in patients with severe Chagas' disease. Levels of soluble platelet endothelial cell adhesion molecule-1 (s-PECAM-1) were significantly increased in the plasma of patients with severe Chagas' disease while unaltered levels of MCP-1 were recorded. These data show that VCAM-1 and P-Selectin ligands are differentially expressed during the chronic phase of the Trypanosoma cruzi infection. These findings also reinforce a role of the P-selectin/SLe(x) adhesion pathway rather than very late antigen-4 (VLA-4)/VCAM-1, in the pathogenesis of Chagas' disease.lld:pubmed
pubmed-article:11309161pubmed:languageenglld:pubmed
pubmed-article:11309161pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:citationSubsetIMlld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11309161pubmed:statusMEDLINElld:pubmed
pubmed-article:11309161pubmed:monthMaylld:pubmed
pubmed-article:11309161pubmed:issn0300-9475lld:pubmed
pubmed-article:11309161pubmed:authorpubmed-author:SeguraE LELlld:pubmed
pubmed-article:11309161pubmed:authorpubmed-author:RiarteAAlld:pubmed
pubmed-article:11309161pubmed:authorpubmed-author:ZapataJJlld:pubmed
pubmed-article:11309161pubmed:authorpubmed-author:LaucellaS ASAlld:pubmed
pubmed-article:11309161pubmed:authorpubmed-author:PradoNNlld:pubmed
pubmed-article:11309161pubmed:issnTypePrintlld:pubmed
pubmed-article:11309161pubmed:volume53lld:pubmed
pubmed-article:11309161pubmed:ownerNLMlld:pubmed
pubmed-article:11309161pubmed:authorsCompleteYlld:pubmed
pubmed-article:11309161pubmed:pagination514-9lld:pubmed
pubmed-article:11309161pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:meshHeadingpubmed-meshheading:11309161...lld:pubmed
pubmed-article:11309161pubmed:year2001lld:pubmed
pubmed-article:11309161pubmed:articleTitlealpha 4 Integrins and sialyl Lewis x modulation in chronic Chagas disease: further evidence of persistent immune activation.lld:pubmed
pubmed-article:11309161pubmed:affiliationInstituto Nacional de Parasitología Dr Mario Fatala Chabén, Ministerio de Salud y Acción Social, Buenos Aires, Argentina. slaucella@yahoo.comlld:pubmed
pubmed-article:11309161pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11309161pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed